PRELUDE THERAPEUTICS INC (PRLD) Operating income 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual operating income history from SEC filings — each fiscal year as reported.
-$104.6MFY2025 · since FY2019: -$28.1M → -$104.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$104.6M | +25.2% |
| FY2024 | -$139.7M | -5.6% |
| FY2023 | -$132.3M | -7.1% |
| FY2022 | -$123.5M | -8.6% |
| FY2021 | -$113.7M | -93.5% |
| FY2020 | -$58.8M | -109.1% |
| FY2019 | -$28.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PRLD financial trends
PRLD RevenuePRLD Net incomePRLD Net marginPRLD Gross profitPRLD Gross marginPRLD Operating marginPRLD Operating cash flowPRLD Free cash flowPRLD Capital expendituresPRLD Return on equityPRLD Stock buybacksPRLD Dividends paidPRLD Total assetsPRLD Total liabilitiesPRLD Shareholders’ equityPRLD overview →